What is BrightInsight?
BrightInsight operates a sophisticated, global platform specifically engineered for the biopharma and medtech sectors. The company provides the essential digital infrastructure required to build, scale, and optimize regulated health solutions, including Software as a Medical Device (SaMD) and complex disease management applications. By offering a secure, compliant environment, BrightInsight allows life sciences organizations to focus on clinical outcomes while the platform handles the technical complexities of connectivity and regulatory adherence. Its market position is defined by its ability to deliver measurable clinical and business ROI, serving as a critical partner for top-tier firms seeking to modernize patient experiences through digital transformation.
How much funding has BrightInsight raised?
BrightInsight has raised a total of $179M across 4 funding rounds:
Series A
$25M
Series B
$40M
Series C
$101M
Unspecified
$13M
Series A (2019): $25M with participation from New Leaf Venture Partners and Eclipse Ventures
Series B (2020): $40M led by New Leaf Venture Partners, Eclipse, and Insight Partners
Series C (2021): $101M supported by New Leaf Venture Partners, Eclipse Ventures Incorporated, General Catalyst Partners, and Insight Partners
Unspecified (2026): $13M featuring Insight Partners, Mayo Clinic, New Leaf Venture Partners, and General Catalyst
Key Investors in BrightInsight
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth software and technology companies, providing hands-on operational support to help businesses scale from early stage to IPO.
General Catalyst
General Catalyst is a venture capital firm focused on identifying and supporting transformational business opportunities across multiple sectors, including healthcare and enterprise software, by providing strategic capital and operational guidance.
New Leaf Venture Partners
New Leaf Venture Partners is a specialized venture capital firm dedicated to funding innovative companies in the healthcare sector, aiming to support transformative technologies that improve patient care and health outcomes.
What's next for BrightInsight?
With the successful closure of its latest financing round, BrightInsight is well-positioned to deepen its penetration into the enterprise digital health market. The strategic focus will likely shift toward enhancing its platform's interoperability and expanding its suite of data insight tools to support more complex therapeutic areas. As the regulatory landscape for digital health continues to evolve, BrightInsight's ability to provide a stable, compliant foundation will be a key differentiator. Future growth will likely involve scaling its operational support for global biopharma partners, further cementing its role as the backbone of modern, connected healthcare ecosystems.
See full BrightInsight company page
